NaturalNews article discussing dietary restriction, ketones, and possible immune effects relevant to cancer immunotherapy.
Dichloroacetate / DCA Metabolic Therapy
DCA is promoted as a metabolic therapy targeting pyruvate dehydrogenase kinase and the Warburg effect. Dichloroacetate has preclinical and early clinical oncology interest through metabolic targeting. It is also promoted online as an alternative cancer therapy. Human clinical use remains investigational, with neuropathy and safety issues requiring clinician oversight.
Nutrients review on pancreatic cancer cachexia, systemic inflammation, metabolic derangement, muscle atrophy, survival, and quality-of-life impact.
Clinical trial reporting metabolic and immune changes from cyclic fasting-mimicking diet with standard antitumor therapies.
Peer-reviewed overview of DCA as metabolic-targeting therapy; relevant both to legitimate research and alternative self-treatment claims.